COM:CRINETICS
Crinetics Pharmaceuticals
- Stock
Last Close
57.03
22/11 21:00
Market Cap
4.01B
Beta: -
Volume Today
1.02M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
net income | -6.02M - | -9.16M 52.13% | -27.11M 196.11% | -50.42M 85.96% | -73.81M 46.39% | -107.64M 45.83% | -163.92M 52.28% | -214.53M 30.88% | |
depreciation and amortization | 92K - | 128K 39.13% | 471K 267.97% | 887K 88.32% | 948K 6.88% | 922K 2.74% | 983K 6.62% | 1.10M 11.70% | |
deferred income tax | -1.23M - | -227K 81.53% | 422K 285.90% | -28.48M - | |||||
stock based compensation | 270K - | 271K 0.37% | 2.32M 756.09% | 6.29M 171.29% | 10.43M 65.67% | 17.35M 66.41% | 28.27M 62.91% | 40.94M 44.82% | |
change in working capital | 189K - | -721K 481.48% | 5.30M 834.81% | -2.13M 140.26% | 376K 117.63% | 1.10M 191.49% | 18.61M 1,598.18% | 8.04M 56.78% | |
accounts receivables | 2.72M - | 6.29M 131.11% | 10.99M 74.70% | 14.65M 33.24% | |||||
inventory | -2.72M - | -6.29M 131.11% | -14.65M - | ||||||
accounts payables | 300K - | 47K 84.33% | 7.36M 15,561.70% | 696K 90.54% | 2.72M 291.24% | 6.29M 131.11% | 10.99M 74.70% | 14.65M 33.24% | |
other working capital | -111K - | -768K 591.89% | -2.06M 168.62% | -2.83M 37.13% | -2.35M 17.04% | -5.20M 121.43% | -3.38M 35.04% | -6.60M 95.62% | |
other non cash items | -433K - | 222K 151.27% | 261K 17.57% | -739K 383.14% | 850K 215.02% | 26.63M 3,032.71% | |||
net cash provided by operating activities | -5.47M - | -9.48M 73.35% | -19.46M 105.29% | -46.38M 138.35% | -62.03M 33.73% | -88.59M 42.82% | -115.20M 30.05% | -166.31M 44.36% | |
investments in property plant and equipment | -190K - | -304K 60% | -1.06M 248.36% | -492K 53.54% | -186K 62.20% | -436K 134.41% | -1.66M 279.82% | -4.69M 183.09% | |
acquisitions net | -1.23M - | -227K 81.53% | 422K 285.90% | 34K 91.94% | |||||
purchases of investments | -118.40M - | -108.14M 8.67% | -135.59M 25.39% | -125.40M 7.51% | -329.82M 163.00% | -532.86M 61.56% | |||
sales maturities of investments | 150.29M - | 136.00M 9.51% | 69.36M 49.00% | 157.49M 127.08% | 337.13M 114.06% | ||||
other investing activites | 1.23M - | 227K 81.53% | -422K 285.90% | -34K 91.94% | |||||
net cash used for investing activites | -190K - | -304K 60% | -119.46M 39,195.39% | 41.67M 134.88% | 217K 99.48% | -56.48M 26,129.03% | -173.98M 208.02% | -200.41M 15.19% | |
debt repayment | -48K - | -212K 341.67% | |||||||
common stock issued | 106.47M - | 126K 99.88% | 114.28M 90,600.79% | 249.54M 118.35% | 117.24M 53.02% | 388.94M 231.74% | |||
common stock repurchased | -5K - | -59K - | |||||||
dividends paid | |||||||||
other financing activites | 12.04M - | 63.73M 429.51% | 67K 99.89% | 288K 329.85% | 3.14M 989.24% | 4.72M 50.49% | |||
net cash used provided by financing activities | -53K - | 11.82M 22,407.55% | 170.20M 1,339.55% | 67K 99.96% | 114.57M 170,901.49% | 252.68M 120.54% | 121.96M 51.73% | 388.94M 218.90% | |
effect of forex changes on cash | 1.00K - | ||||||||
net change in cash | -5.71M - | 2.04M 135.72% | 31.28M 1,433.38% | -4.65M 114.86% | 52.76M 1,235.38% | 107.61M 103.95% | -167.22M 255.40% | 22.23M 113.29% | |
cash at beginning of period | 17.86M - | 12.15M 31.97% | 14.19M 16.79% | 45.47M 220.41% | 40.83M 10.22% | 93.59M 129.23% | 201.19M 114.98% | 32.67M 83.76% | |
cash at end of period | 12.15M - | 14.19M 16.79% | 45.47M 220.41% | 40.83M 10.22% | 93.59M 129.23% | 201.19M 114.98% | 33.97M 83.11% | 54.90M 61.59% | |
operating cash flow | -5.47M - | -9.48M 73.35% | -19.46M 105.29% | -46.38M 138.35% | -62.03M 33.73% | -88.59M 42.82% | -115.20M 30.05% | -166.31M 44.36% | |
capital expenditure | -190K - | -304K 60% | -1.06M 248.36% | -492K 53.54% | -186K 62.20% | -436K 134.41% | -1.66M 279.82% | -4.69M 183.09% | |
free cash flow | -5.66M - | -9.78M 72.91% | -20.52M 109.73% | -46.87M 128.45% | -62.21M 32.73% | -89.02M 43.10% | -116.86M 31.27% | -171.00M 46.32% |
All numbers in USD (except ratios and percentages)